Rocket Pharmaceuticals Inc logo

Rocket Pharmaceuticals Inc

RCKT
Healthcare|Biotechnology|USA
$3.91
-0.28 (-6.68%)
Tangible Book
$1.59
Earnings Power
$0.30

Clinical Trials (37)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT07209787
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
Rectal Cancer
P4
Recruiting966RCT, Open-label
NCT06312982
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
Locally Advanced Rectal Carcinoma
P2P3
Recruiting375RCT, Single-blindTislelizumab
NCT06092034
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Danon Disease
P2
Recruiting14Open-label
NCT04248439
Gene Therapy for Fanconi Anemia, Complementation Group A
Fanconi Anemia Complementation Group A
P2
Active5Open-labelRP-L102
NCT07137338
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Dilated Cardiomyopathy (DCM)
P1
Recruiting8Open-label
NCT05885412
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
P1
Recruiting9Open-label
NCT06644742
PKP2-ACM Natural History Study
Cardiomyopathies, Heart Diseases
Recruiting36
NCT06282432
Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)
Leukocyte Adhesion Deficiency
Active9
NCT06214507
Danon Disease Natural History Study
Danon Disease
Recruiting60
NCT04437771
Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy
Fanconi Anemia Complementation Group A, Fanconi Anemia
Active9
NCT07369830
The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
Rectal Cancer
N/A
Recruiting156RCT, Open-labelClostridium butyricum (live) Tablets(Meiya)
NCT03831386
Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System
Pleural Effusion
N/A
Recruiting200RCT, Open-label
NCT07333053
Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer
Unresectable Colorectal Cancer
N/A
Recruiting30RCT, Open-label
NCT06662643
A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection
Rectal Cancer, Rectal Carcinoma
N/A
Active110RCT, Single-blind
NCT02937974
Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD
Pulmonary Disease, Chronic Obstructive
P4
Unknown254RCT, Double-blindXuebijing, Placebo
NCT07509398
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer
Unresectable Colorectal Cancer, Colorectal Cancer (Locally Advanced or Metastatic)
P2P3
Not Yet Recruiting220RCT, Open-labelStandard First-Line Therapy
NCT06422351
Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency
Pyruvate Kinase Deficiency
P2
SUSPENDED10Open-labelRP-L301
NCT04069533
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
Fanconi Anemia Complementation Group A
P2
Unknown7Open-labelRP-L102
NCT03812263
A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I
Leukocyte Adhesion Defect - Type I
P1P2
Completed9Open-labelRP-L201
NCT03825783
A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I
Leukocyte Adhesion Defect - Type I
P1
WithdrawnOpen-labelRP-L201
NCT03882437
Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
Danon Disease
P1
Unknown7Open-labelRP-A501
NCT04525352
A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis
Infantile Malignant Osteopetrosis
P1
Terminated1Open-labelRP-L401
NCT03814408
A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A
Fanconi Anemia Complementation Group A
P1
Unknown2Open-labelRP-L102
NCT04105166
Gene Therapy for Pyruvate Kinase Deficiency (PKD)
Pyruvate Kinase Deficiency
P1
Completed4Open-labelRP-L301
NCT01331018
Gene Therapy for Fanconi Anemia
Fanconi Anemia
P1
Terminated3Open-labelFilgrastim, Genetically Engineered Hematopoietic Stem Progenitor Cells, Methylprednisolone, Plerixafor, Prednisone
NCT05548855
Natural History of Danon Disease
Danon Disease
Completed59
NCT07527975
Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102
Fanconi Anemia
By Invite14RP-L102
NCT07486752
BAG3-DCM Natural History Study
Dilated Cardiomyopathy (DCM), Cardiovascular Diseases
Not Yet Recruiting30
NCT03766386
The Natural History of Danon Disease
Danon Disease
Unknown200
NCT03319186
EDIT Management Feasibility Trial
Pleural Effusion, Malignant
N/A
Unknown30RCT, Open-label
NCT04793607
Interventions for Malignant Pleural Effusions Impact on Fatigue
Malignant Pleural Effusion
Unknown50
NCT06082414
Systemic Management in Extremely Preterm and Extremely Low Birth Weight Infants
Bronchopulmonary Dysplasia, Death
Completed1,200
NCT03661801
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Respiratory Disease, Pleural Effusion
Completed313
NCT04967729
COVID-19 and Lung Ultrasound Utility
Covid19
N/A
Completed26Open-label
NCT02805062
Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy
Pleural Effusion, Malignant
Unknown65
NCT03311165
Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)
Neonatal Acute Respiratory Distress Syndrome(ARDS)
Completed1,000
NCT05727358
Effectiveness of Group Acceptance and Commitment Therapy in Treating Acute Stroke Patients With Depression
Acute Stroke Patients With Depression
N/A
Completed139RCT, Double-blind